Hematologic Oncology Update cover image

Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting

Hematologic Oncology Update

00:00

The Rooks O'Lithin

There are multiple different reports associating the small spleen with much better durability and the longevity of that patient. The other part is when do we need to intervene to get the best out of it, right? I remember the time when the Rooks O'Lithin was approved in 2011 when they say, oh, it's a palliative care. It's for those that go to hospice and nothing else to do. And then we learn that it can't possibly extend life for a few years, three years and average in clinical studies. But thinking is not really what the standard practice at the moment is.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app